Bouchey Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Buy
1,165
+42
+4% +$42.6K 0.08% 53
2025
Q4
$1.21M Buy
1,123
+34
+3% +$32.5K 0.09% 49
2025
Q3
$831K Sell
1,089
-3
-0.3% -$2.23K 0.06% 58
2025
Q2
$851K Buy
1,092
+1
+0.1% +$777 0.07% 56
2025
Q1
$901K Sell
1,091
-16
-1% -$13.3K 0.08% 50
2024
Q4
$855K Sell
1,107
-34
-3% -$28.2K 0.07% 49
2024
Q3
$1.01M Sell
1,141
-2
-0.2% -$1.8K 0.09% 50
2024
Q2
$1.03M Sell
1,143
-55
-5% -$44K 0.1% 45
2024
Q1
$932K Buy
1,198
+45
+4% +$32K 0.09% 48
2023
Q4
$672K Hold
1,153
0.07% 53
2023
Q3
$620K Buy
+1,153
New +$594K 0.08% 55

Other funds holding LLY

Bouchey Financial Group's LLY Position: Q1 2026 in Review

Bouchey Financial Group increased its Eli Lilly (LLY) stake by 3.7% in Q1 2026, buying an estimated $42.6K and bringing the position to 1,165 shares worth $1.11M. The position accounts for 0.08% of the portfolio, ranked #53.

Bouchey Financial Group first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.21M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bouchey Financial Group held 1,165 shares of Eli Lilly worth $1.11M as of Q1 2026.
  • Bouchey Financial Group bought 42 Eli Lilly shares in Q1 2026, an estimated $42.6K.
  • Eli Lilly made up 0.08% of Bouchey Financial Group's portfolio in Q1 2026, its #53 holding.
  • Bouchey Financial Group first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Bouchey Financial Group's Eli Lilly position peaked at $1.21M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bouchey Financial Group's 13F filing for Q1 2026, filed 13 Apr 2026.